Hasil Filter

6694

Total database: 17430
Struktur (SMILES)
4518 (67.5%)
Target
3751 (56.0%)
Genomik
81 (1.2%)
Referensi
6694 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (6694)

Halaman 38 / 134
Cidofovir Approved DB00369
small molecule | CAS: 113852-37-2

Cidofovir is an injectable antiviral medication employed in the treatment of cytomegalovirus (CMV) retinitis in patients diagnosed with AIDS. It suppresses CMV replication through selective inhibition of viral DNA synthesis.[FDA label] It was manufactured by …

Kategori:
Anti-Infective AgentsAntiinfectives for Systemic UseAntiviral Agents +16
Target Protein:
DNA polymerase catalytic subunitDNA polymerase catalytic subunit
Waktu Paruh2.4 to 3.2 hours
Vol. Distribusi* 537 ± 126 mL/kg […
Klirens* 179 +/- 23.1 mL/m…
Genetik -
Cidoxepin DB14750
small molecule | CAS: 3607-18-9

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Ciforadenant DB16125
small molecule | CAS: 1202402-40-1

Ciforadenant is under investigation in clinical trial NCT02253745 (Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)).

Target Protein:
Adenosine receptor A2a
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

CIGB 2020 is a vaccine candidate administered nasally and sublingually, working to strengthen immunity in the areas administered. The vaccine was developed and tested by the Center for Genetic Engineering and Biotechnology (CIGB), in Havana Cuba. As of July, …

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CIGB 300 DB16464
biotech | CAS: 1072877-99-6

CIGB-300, is under investigation in clinical trials for its potential to treat various conditions, including NCT01639638 (recurrent and nonrecurrent condyloma) and NCT01639625 (squamous cell carcinoma and adenocarcinoma of the cervix)

Kategori:
Amino Acids, Peptides, and ProteinsExperimental Unapproved Treatments for COVID-19Peptides
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

CIGB-258 is a peptide that is immunoregulatory and derived from heat shock protein 60 of the cellular variant. As of 2020, The Center for Genetic Engineering and Biotechnology (CIGB) in Havana, Cuba, is testing the treatment efficacy of this peptide in patien…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Ciglitazone DB09201
small molecule | CAS: 74772-77-3

Developed by Takeda Pharmaceuticals in the early 1980s, it is considered the prototypical compound for the thiazolidinedione class. Ciglitazone was never used as a medication, but it sparked interest in the effects of thiazolidinediones. Several analogues …

Kategori:
Blood Glucose Lowering AgentsCytochrome P-450 CYP2C8 InhibitorsCytochrome P-450 CYP2C8 Inhibitors (strength unknown) +8
Target Protein:
Peroxisome proliferator-activated receptor gamma
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cilansetron DB04885
small molecule | CAS: 120635-74-7

Cilansetron is a 5HT-3 antagonist made by Solvay Pharmaceuticals that is currently under trial phase in the EU and US.

Kategori:
Alimentary Tract and MetabolismAntidepressive AgentsCentral Nervous System Depressants +5
Target Protein:
5-hydroxytryptamine receptor 3A
Waktu ParuhThe elimination hal…
Vol. Distribusi-
Klirens-
Genetik -
Cilastatin Approved DB01597
small molecule | CAS: 82009-34-5

Cilastatin is an inhibitor of renal dehydropeptidase, an enzyme responsible for both the metabolism of thienamycin beta-lactam antibiotics as well as conversion of leukotriene D4 to leukotriene E4. Since the antibiotic, [imipenem], is one such antibiotic that…

Kategori:
CycloparaffinsCyclopropanesDipeptidase Inhibitors +5
Target Protein:
Dipeptidase 1
Waktu ParuhThe half-life of ci…
Vol. DistribusiCilastatin has a vo…
KlirensCilastatin has a to…
Genetik -
Cilazapril Approved DB01340
small molecule | CAS: 88768-40-5

Cilazapril is an ACE inhibtor class drug used in the treatment of hypertension and heart failure. It belongs to the angiotensin-converting enzyme inhibitors (ACE inhibitors) class of drugs. It is a prodrug that is hydrolyzed after absorption to its main meta…

Kategori:
ACE Inhibitors and DiureticsAgents Acting on the Renin-Angiotensin SystemAgents causing angioedema +10
Target Protein:
Angiotensin-converting enzyme
Waktu ParuhHalf-lives for the …
Vol. Distribusi-
KlirensTotal clearance is …
Genetik -
Cilazaprilat DB15565
small molecule | CAS: 90139-06-3

Deskripsi belum tersedia.

Kategori:
Agents Acting on the Renin-Angiotensin SystemAngiotensin-Converting Enzyme InhibitorsAntihypertensive Agents +4
Target Protein:
Angiotensin-converting enzyme
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cilengitide DB11890
small molecule | CAS: 188968-51-6

Cilengitide has been used in trials studying the treatment of Sarcoma, Gliomas, Lymphoma, Leukemia, and Lung Cancer, among others.

Kategori:
Biological FactorsComplex MixturesToxins, Biological +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cilgavimab Approved DB16393
biotech | CAS: 2420563-99-9

SARS-CoV-2, the causative agent of COVID-19, enters cells via the interaction between the trimeric spike (S) glycoprotein and host cell angiotensin-converting enzyme 2 (ACE2). Blocking the interaction between the receptor-binding domain (RBD) of the S1 subuni…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +12
Target Protein:
Spike glycoprotein
Waktu ParuhCilgavimab has a ha…
Vol. DistribusiCilgavimab has an a…
KlirensCilgavimab has an a…
Genetik -
biotech | CAS: 133423-39-9

NT-501 is an intraocular implant that contains human cells that have been genetically modified to secrete ciliary neurotrophic factor (CNTF).[L46762] It is under investigation for the treatment of retinitis pigmentosa and age-related macular degeneration.

Kategori:
Amino Acids, Peptides, and ProteinsBiological FactorsIntercellular Signaling Peptides and Proteins +4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cilnidipine DB09232
small molecule | CAS: 132203-70-4

Cilnidipine is a dihydropyridine calcium antagonist. It was jointly developed by Fuji Viscera Pharmaceutical Company, Japan and Ajinomoto, Japan and approved in 1995. Compared with other calcium antagonists, cilnidipine can act on the N-type calcium channel t…

Kategori:
Agents causing hyperkalemiaAntiarrhythmic agentsBradycardia-Causing Agents +12
Target Protein:
Voltage-dependent N-type calcium channel subunit alpha-1BVoltage-dependent L-type calcium channel
Waktu ParuhThe half-life of th…
Vol. DistribusiDrugs on the group …
Klirens-
Genetik -
Cilofexor DB15168
small molecule | CAS: 1418274-28-8

Cilofexor is under investigation in clinical trial NCT02943447 (Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis).

Kategori:
AzetinesPyridines
Target Protein:
Bile acid receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cilomilast DB03849
small molecule | CAS: 153259-65-5

Cilomilast (Ariflo, SB-207,499) is a drug which was developed for the treatment of respiratory disorders such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It is orally active and acts as a selective Phosphodiesterase-4 inhibitor. Following four…

Kategori:
Acids, CarbocyclicCyclohexanesCycloparaffins +3
Target Protein:
3',5'-cyclic-AMP phosphodiesterase 4D3',5'-cyclic-AMP phosphodiesterase 4A3',5'-cyclic-AMP phosphodiesterase 4B
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cilostazol Approved DB01166
small molecule | CAS: 73963-72-1

Cilostazol is a quinolinone derivative and antiplatelet agent with vasodilating properties that has been used in the symptomatic treatment of intermittent claudication in patients with peripheral ischaemia. It is marketed under the brand name Pletal by Otsuka…

Kategori:
Agents producing tachycardiaAnti-Asthmatic AgentsAntiplatelet agents +31
Target Protein:
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A
Waktu Paruh11-13 hours.
Vol. Distribusi-
Klirens-
Genetik -
Ciltacabtagene autoleucel Approved DB16738
biotech

Multiple myeloma is a malignancy involving the plasma cells of the bone marrow. It is a rare malignancy, with an estimated yearly incidence of 6.5 people per 100,000,[L40749] and is variable in its presentation - some patients may remain entirely asymptomatic…

Kategori:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsAntineoplastic cell and gene therapy
Target Protein:
Tumor necrosis factor receptor superfamily member 17
Waktu ParuhThe median half-lif…
Vol. Distribusi-
Klirens-
Genetik -
Ciluprevir DB05868
small molecule | CAS: 300832-84-2

The compound, named BILN 2061, is an orally active inhibitor of the HCV NS3 protease and the first member of this new drug class to be tested in humans.

Kategori:
Acids, AcyclicHeterocyclic Compounds, Fused-RingSulfur Compounds
Target Protein:
Genome polyprotein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cimetidine Approved DB00501
small molecule | CAS: 51481-61-9

A histamine congener, it competitively inhibits histamine binding to histamine H2 receptors. Cimetidine has a range of pharmacological actions. It inhibits gastric acid secretion, as well as pepsin and gastrins output. It also blocks the activity of cytochrom…

Kategori:
Acid ReducersAdjuvantsAgents Causing Muscle Toxicity +53
Target Protein:
Histamine H2 receptor
Waktu ParuhCimetidine's half-l…
Vol. DistribusiThe volume of distr…
KlirensCimetidine's report…
Genetik -
Cimetropium DB09271
small molecule | CAS: 150521-16-7

Cimetropium is a semi-synthetic belladonna alkaloid and derivative of scopolamine. It is a potent antimuscarinic and an effective antispasmodic drug. It is also endowed of a direct myolitic action which partially accounts for its antispasmodic activity. It ha…

Kategori:
Alimentary Tract and MetabolismAlkaloidsAutonomic Agents +8
Target Protein:
Muscarinic acetylcholine receptor M5
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cimicoxib DB05095
small molecule | CAS: 265114-23-6

Cimicoxib is a selective COX-2 inhibitor being developed by Affectis as a treatment for depression and schizophrenia. If approved, Cimicoxib would be the first drug in decades to treat depression by a new mechanism of action.

Kategori:
Agents causing hyperkalemiaAgents that produce hypertensionAmides +6
Target Protein:
Prostaglandin G/H synthase 2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cimlanod DB14983
small molecule | CAS: 1620330-72-4

Cimlanod is under investigation in clinical trial NCT02819271 (A First-in-Human Study of the Safety of Single Continuous Intravenous (IV) Infusions of CXL-1427 for up to 48 Hours in Healthy Volunteers).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinacalcet Approved DB01012
small molecule | CAS: 226256-56-0

Cinacalcet is a calcimimetic sold by Amgen under the trade name Sensipar® in North America and Australia and as Mimpara® in Europe. It is used to treat hyperparathyroidism due to parathyroid tumours or renal failure.

Kategori:
Anti-Parathyroid AgentsCalcimimetic AgentsCalcium Homeostasis +15
Target Protein:
Extracellular calcium-sensing receptor
Waktu ParuhTerminal half-life …
Vol. Distribusi* 1000 L
Klirens-
Genetik -
Cinaciguat DB16126
small molecule | CAS: 329773-35-5

Cinaciguat is under investigation in clinical trial NCT01067859 (A Phase Iib Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 ?G/h, 10 ?G/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Fail…

Kategori:
Acids, CarbocyclicBenzene DerivativesGuanylate Cyclase
Target Protein:
Guanylate cyclase soluble subunit beta-1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinalukast DB00587
small molecule | CAS: 128312-51-6

Used in the treatment of asthma, cinalukast selectively antagonizes leukotriene D4 (LTD4) at the cysteinyl leukotriene receptor, CysLT1, in the human airway. Cinalukast inhibits the actions of LTD4 at the CysLT1 receptor, preventing airway edema, smooth muscl…

Kategori:
Sulfur Compounds
Target Protein:
Cysteinyl leukotriene receptor 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinazepam DB14715
small molecule | CAS: 172986-25-3

Deskripsi belum tersedia.

Kategori:
BenzazepinesBenzodiazepines and benzodiazepine derivativesCentral Nervous System Depressants +1
Target Protein:
GABA(A) ReceptorGABA(A) Receptor Benzodiazepine Binding Site
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinchocaine Approved DB00527
small molecule | CAS: 85-79-0

A local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. (From Martindale, The Extra Pharmacopoeia, 3…

Kategori:
Agents for Treatment of Hemorrhoids and Anal Fissures for Topical UseAmidesAnalgesics and Anesthetics +22
Target Protein:
Sodium channel protein type 5 subunit alphaSodium channel protein type 10 subunit alphaCalmodulin
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinchonidine DB16831
small molecule | CAS: 485-71-2

Deskripsi belum tersedia.

Kategori:
Alkaloids
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinchophen DB13551
small molecule | CAS: 132-60-5

Deskripsi belum tersedia.

Kategori:
Antigout PreparationsHeterocyclic Compounds, Fused-RingMusculo-Skeletal System +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinepazet DB13342
small molecule | CAS: 23887-41-4

Deskripsi belum tersedia.

Kategori:
Cardiac TherapyVasodilators Used in Cardiac Diseases
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinepazide DB12123
small molecule | CAS: 23887-46-9

Cinepazide has been used in trials studying the treatment of Ischemic Stroke.

Kategori:
Cardiovascular AgentsPeripheral VasodilatorsVasodilating Agents
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinitapride DB08810
small molecule | CAS: 66564-14-5

Cinitapride is a gastroprokinetic agent and antiulcer benzamide with agonist activity at 5-HT1 and 5-HT4 receptors and antagonist activity at 5-HT2 receptors. It is marketed in Spain and Mexico.

Kategori:
Acids, CarbocyclicAgents that produce hypertensionAlimentary Tract and Metabolism +16
Target Protein:
5-hydroxytryptamine receptor 1A5-hydroxytryptamine receptor 2A5-hydroxytryptamine receptor 4
Waktu Paruh3-5 h during the fi…
Vol. Distribusi-
Klirens-
Genetik -
Cinnamaldehyde Approved DB14184
small molecule | CAS: 14371-10-9

Cinnamaldehyde is a naturally occurring flavonoid that gives the spice cinnamon its flavour and odour. It occurs naturally in the bark of cinnamon trees and other species of the genus Cinnamomum such as camphor and cassia. Sensitivity to cinnamaldehyde ma…

Kategori:
AldehydesAntimutagenic AgentsAntineoplastic Agents +15
Target Protein:
Transient receptor potential cation channel subfamily V member 3Transient receptor potential cation channel subfamily A member 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinnamic acid DB18313
small molecule | CAS: 140-10-3

Deskripsi belum tersedia.

Kategori:
Acids, CarbocyclicAnticoagulantsCarbohydrates +8
Target Protein:
Hydroxycarboxylic acid receptor 2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinnamon Approved DB10520
biotech

Cinnamon allergenic extract is used in allergenic testing.

Kategori:
Cell-mediated ImmunityIncreased Histamine ReleaseNon-Standardized Food Allergenic Extract
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech | CAS: 8015-91-6

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinnamon oil Approved DB15986
biotech | CAS: 8007-80-5

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinnamyl alcohol Approved DB14186
small molecule | CAS: 4407-36-7

Cinnamyl alcohol is a naturally occurring compound that is found within cinnamon. Due to the low levels found in cinnamon, cinnamyl alcohol is usually supplied as [DB14184] within commercial products. Cinnamyl alcohol has been shown to be a skin sensitizer…

Kategori:
AlcoholsCell-mediated ImmunityDrugs that are Mainly Renally Excreted +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinnarizine Approved DB00568
small molecule | CAS: 298-57-7

First synthesized by Janssen Pharmaceuticals in 1955, cinnarizine is an anti-histaminic drug mainly used for the control of vestibular disorders and motion sickness. Cinnarizine is a specific calcium channel blocker that primarily works on the central vestibu…

Kategori:
Agents causing hyperkalemiaAntiarrhythmic agentsAntivertigo Preparations +22
Target Protein:
Histamine H1 receptorVoltage-dependent L-type calcium channel subunit alpha-1CVoltage-dependent L-type calcium channel subunit alpha-1D +8
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinolazepam DB01594
small molecule | CAS: 75696-02-5

Cinolazepam is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant activity. It is not approved in Canada or America.

Kategori:
BenzazepinesBenzodiazepine hypnotics and sedativesBenzodiazepines and benzodiazepine derivatives +5
Target Protein:
Translocator proteinGABA(A) ReceptorGABA(A) Receptor Benzodiazepine Binding Site
Waktu Paruh9 hours
Vol. Distribusi-
Klirens-
Genetik -
Cinoxacin Approved DB00827
small molecule | CAS: 28657-80-9

Synthetic antimicrobial related to oxolinic acid and nalidixic acid and used in urinary tract infections.

Kategori:
Anti-Bacterial AgentsAnti-Infective AgentsAntibacterials for Systemic Use +12
Target Protein:
DNA gyrase subunit ADNA topoisomerase 2-betaDNA topoisomerase 2-alpha +1
Waktu ParuhWhile the mean seru…
Vol. Distribusi-
Klirens-
Genetik -
Cinoxate Approved DB15467
small molecule | CAS: 104-28-9

Deskripsi belum tersedia.

Kategori:
Acids, CarbocyclicSunscreen Agents
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cinpanemab DB16127
biotech | CAS: 2094516-02-4

Cinpanemab is under investigation in clinical trial NCT03318523 (Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech | CAS: 2218515-90-1

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech | CAS: 372075-36-0

Cintredekin besudotox has been developed as a specific tumor-targeting agent, which is administered by positive-pressure convection-enhanced delivery (CED) directly to brain tissue at risk for residual infiltrating glioblastoma multiforme (GBM) after tumor re…

Kategori:
Amino Acids, Peptides, and ProteinsBiological FactorsCytokines +6
Target Protein:
Interleukin-13
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cipaglucosidase alfa Approved DB16708
biotech | CAS: 2359727-71-0

Cipaglucosidase alfa (ATB200) is a novel recombinant human acid alpha-glucosidase (GAA) investigated for the treatment of patients with Pompe disease, a rare inherited metabolic disorder characterized by a deficiency in GAA.[A232955] Other types of enzyme rep…

Kategori:
Alimentary Tract and MetabolismEnzyme Replacement TherapyEnzymes +1
Target Protein:
Cation-independent mannose-6-phosphate receptor
Waktu ParuhThe mean terminal e…
Vol. DistribusiThe mean volume of …
KlirensCoadministration of…
Genetik -
Cipargamin DB12306
small molecule | CAS: 1193314-23-6

Cipargamin has been used in trials studying the treatment of Malaria, Cure Rate, and Plasmodium Falciparum Malaria.

Kategori:
Heterocyclic Compounds, Fused-Ring
Target Protein:
Adenosine receptor A3Voltage-gated inwardly rectifying potassium channel KCNH2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cipatinib DB16752
small molecule

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Menampilkan 1851–1900 dari 6694
Sebelumnya Halaman 38 / 134 Berikutnya